Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10967004 | Vaccine | 2013 | 8 Pages |
Abstract
⺠This study models the impact of varicella vaccination in the Colombian population. ⺠Mass vaccination against varicella is cost-effective in Colombia from the third-payer perspective. ⺠Uncertainty of varicella vaccine impact on Herpes-zoster may change cost effectiveness results. ⺠Developing countries similar to Colombia with high varicella case-fatality rates may benefit from results of our study.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Angel Paternina-Caicedo, Fernando De la Hoz-Restrepo, Oscar Gamboa-Garay, Carlos Castañeda-Orjuela, Martha Velandia-González, Nelson Alvis-Guzmán,